Bio-Techne (NASDAQ:TECH) Given New $75.00 Price Target at Royal Bank of Canada
Bio-Techne (NASDAQ:TECH – Get Free Report) had its target price cut by investment analysts at Royal Bank of Canada from $85.00 to $75.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “sector perform” rating on the biotechnology company’s stock. Royal Bank of Canada’s price target points to a potential […]